Management of Relapsing-Remitting Multiple Sclerosis: Defining the Role of Subcutaneous Recombinant Interferon- -1a (Rebif)

By Lyseng-Williamson K.A.   Plosker G.L.  

Disease Management & Health Outcomes, Vol. 10, Iss. 5, 2002-01 ,pp. : 307-325

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Glatiramer Acetate and Natalizumab in Relapsing-Remitting Multiple Sclerosis

By Earnshaw Stephanie R.  

Applied Health Economics and Health Policy, Vol. 7, Iss. 2, 2009-06 ,pp. : 91-108

Adis International

Access to resources Recommend Favorite

Work Productivity and Healthcare Resource Utilization Outcomes for Patients on Etanercept for Moderate-to-Severe Plaque Psoriasis: Results from a 1-Year, Multicentre, Open-Label, Single-Arm Study in a Clinical Setting

By Vender Ronald   Lynde Charles   Ho Vincent  

Applied Health Economics and Health Policy, Vol. 10, Iss. 5, 2012-09 ,pp. : 343-353

Adis International

Access to resources Recommend Favorite

Drug Self-Administration Viewed as Ingestive Behaviour

By Wise R.A.  

Appetite (APPET), Vol. 28, Iss. 1, 1997-01 ,pp. : 1-5

Academic Press

Access to resources Recommend Favorite

Change in quality of life and predictors of change among patients with multiple sclerosis: a prospective cohort study

By Tepavcevic Darija   Pekmezovic Tatjana   Stojsavljevic Nebojsa   Kostic Jelena   Basuroski Irena   Mesaros Sarlota   Drulovic Jelena  

Quality of Life Research, Vol. 23, Iss. 3, 2014-04 ,pp. : 1027-1037

Springer Publishing Company

Access to resources Recommend Favorite